Senior Peter A, Bellin Melena D, Alejandro Rodolfo, Yankey Jon W, Clarke William R, Qidwai Julie C, Schwieger Traci R, Eggerman Thomas L, Robien Mark A, Rickels Michael R
1 Clinical Islet Transplant Program, Division of Endocrinology, University of Alberta , Edmonton, Alberta, Canada .
Diabetes Technol Ther. 2015 Apr;17(4):235-42. doi: 10.1089/dia.2014.0289. Epub 2015 Jan 28.
In long-standing type 1 diabetes (T1D), loss of endogenous insulin secretion and glucose dysregulation can lead to severe hypoglycemia and associated complications. Here, we report the serial consistency and the correlation between different scores that characterize glucose dysregulation using self-monitoring of blood glucose (SMBG), in a cohort of T1D individuals being evaluated for transplant eligibility in Clinical Islet Transplantation Consortium trials.
In total, 152 C-peptide-negative T1D subjects with at least one severe hypoglycemia episode in the prior year documented SMBG at enrollment and every 6 months until deemed ineligible or transplanted. SMBG was used to calculate the HYPO score, Lability Index (LI), and mean amplitude of glycemic excursion (MAGE). Additionally, a blinded continuous glucose monitoring system (CGMS) was worn for 72 h at enrollment and every 12 months.
In this cohort, LI was the most consistent (intraclass correlation coefficient=0.70) over time, followed by the HYPO score (0.51), with MAGE being the least consistent (0.36). Although MAGE and LI were highly correlated with each other, neither correlated with CGMS SD or glucose coefficient of variation (CV). Subjects spent a median of 97 min/day at <54 mg/dL using CGMS. The HYPO score correlated with CGMS time below 54 mg/dL and glucose CV.
The HYPO score and LI are more consistent than MAGE in patients with established T1D experiencing severe hypoglycemic events and may be especially useful both for identifying subjects experiencing the greatest difficulty in maintaining glycemic control and for longitudinal assessment of novel interventions.
在长期的1型糖尿病(T1D)中,内源性胰岛素分泌丧失和血糖失调可导致严重低血糖及相关并发症。在此,我们报告了在临床胰岛移植联盟试验中接受移植资格评估的T1D个体队列中,使用自我血糖监测(SMBG)来表征血糖失调的不同评分之间的系列一致性及相关性。
共有152例C肽阴性的T1D受试者,他们在上一年至少有一次严重低血糖发作,在入组时及之后每6个月记录一次SMBG,直至被判定不符合资格或接受移植。SMBG用于计算低血糖评分(HYPO评分)、血糖波动指数(LI)和血糖波动平均幅度(MAGE)。此外,在入组时和每12个月时佩戴一次盲法连续血糖监测系统(CGMS)72小时。
在该队列中,LI随时间变化最为一致(组内相关系数=0.70),其次是HYPO评分(0.51),MAGE最不一致(0.36)。尽管MAGE和LI彼此高度相关,但两者均与CGMS标准差或血糖变异系数(CV)无关。使用CGMS时,受试者每天处于<54mg/dL的时间中位数为97分钟。HYPO评分与CGMS低于54mg/dL的时间及血糖CV相关。
在经历严重低血糖事件的确诊T1D患者中,HYPO评分和LI比MAGE更具一致性,对于识别在维持血糖控制方面困难最大的受试者以及对新干预措施进行纵向评估可能特别有用。